secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK:        0001267565
Form:       8-K
Filed at:   2025-12-30T23:59:59+00:00
Accession:  0001104659-25-125026
Event type: debt
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 1.02, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Collegium closes $980M syndicated credit facility, repays Pharmakon loan
------------------------------------------------------------------------

- $980M total facility: $580M term loan, $300M delayed draw, $100M revolver; matures 2030.
- Initial term loan used to repay ~$581M of existing Pharmakon debt; previous facility was $646M.
- Interest rate SOFR + 2.75%–3.75% (initial 2.75%), expected to deliver meaningful annualized interest savings.
- Delayed draw and revolver undrawn at close; earmarked for general corporate purposes and M&A.
- Truist Bank administrative agent; bank syndicate includes Citizens, MUFG, Fifth Third, Huntington, U.S. Bank.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267565/000110465925125026/0001104659-25-125026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267565/000110465925125026/tm2534421d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-125026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer